JP Patent

JP4868695B2 — 崩壊性が良好な経口製剤

Assigned to Sumitomo Pharma Co Ltd · Expires 2012-02-01 · 14y expired

What this patent protects

Patent listed against pimavanserin-tartrate.

Drugs covered by this patent

pimavanserin-tartrate (PIMAVANSERIN TARTRATE)

Patent Metadata

Patent number: JP4868695B2
Jurisdiction: JP
Classification: —
Expires: 2012-02-01
Drug substance claim: No
Drug product claim: No
Assignee: Sumitomo Pharma Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.